Improvement in Aortic Stiffness After 9 Months of Antiretroviral Therapy in Treatment-Naïve People Living with HIV

Résumé fourni par la source

Background: People living with HIV (PLWH) are at increased risk of cardiovascular disease (CVD). Aortic stiffness measured with carotid-femoral pulse wave velocity (PWV) is a validated predictor of CVD and has been shown to be elevated in PLWH at HIV diagnosis. Objectives: To prospectively evaluate the effect of 9 months of contemporary antiretroviral therapy (ART) on aortic stiffness in newly diagnosed PLWH. Methods: A group of ART-naïve PLWH with modest cardiovascular risk and without known CVD were recruited at the time of HIV diagnosis. Aortic stiffness was measured using carotid-femoral PWV (ViCorder, Skidmore Medical, UK) before ART initiation and after 9 months on treatment. Results: Seventy-three participants were analysed (mean age 32 ± 7 years; 45% female). PWV decreased significantly after 9 months of ART (5.93 ± 1.0 vs. 5.69 ± 1.0 m/s; p = 0.01) with increased aortic distensibility (0.36 [IQR 0.30 to 0.46] vs. 0.40 [IQR 0.34 to 0.50] mmHg−1; p = 0.02). The reduction in PWV remained significant after adjustment for covariates (mean change −0.26 m/s; 95% CI −0.07 to −0.45; p = 0.01). Conclusions: Aortic stiffness improved in a group of newly diagnosed PLWH after ART initiation at 9 months, in keeping with a modifiable component of HIV-associated vascular dysfunction. The findings are consistent with reversible functional vascular abnormality, potentially mediated by changes in vasomotor tone, although it is unknown if this effect will be sustained long-term. The trajectory of aortic stiffness in PLWH and the mechanisms that underpin vasomotor tone require further study.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.